About Hôpital privé Drôme Ardèche - Clinique Pasteur
"L’Hôpital privé Drôme Ardèche, établissement du groupe Ramsay Santé, est né en 2005, de la réunion de la clinique Pasteur à Guilherand-Granges et de la clinique Générale à Valence. L’établissement dispose de 363 lits et places. Vous y serez pris en charge par une équipe hautement qualifiée au sein d’une structure à taille humaine conçue pour garantir votre confort et votre bien-être. L’hôpital privé Drôme Ardèche, 1er établissement privé du grand bassin valentinois, met à votre disposition des soins de qualité à proximité de votre lieu de vie."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
ARCAGY/ GINECO GROUP
4
Federation Francophone de Cancerologie Digestive
3
Hoffmann-La Roche
3
Hospices Civils de Lyon
2
ATF Implants
1
Association Francaise d'Urologie
1
Centre Leon Berard
1
EUROS
1
Institut Claudius Regaud
1
Institut de Cancérologie de la Loire
1
Janssen Research & Development, LLC
1
Clinical Trials at Hôpital privé Drôme Ardèche - Clinique Pasteur
During the past decade, Hôpital privé Drôme Ardèche - Clinique Pasteur conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
First Line Metastatic Breast Cancer Treatment (ESMERALDA)
2013-11-01
2016-03-01
Completed
61
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital privé Drôme Ardèche - Clinique Pasteur" #1 sponsor was "ARCAGY/ GINECO GROUP" with 4 trials, followed by "Federation Francophone de Cancerologie Digestive" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Hospices Civils de Lyon" with 2 trials sponsored and "ATF Implants"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital privé Drôme Ardèche - Clinique Pasteur"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Institut Paoli-Calmettes" with 1 trials as a collaborator, "PHRC 2007: financial support" with 1 trials as a collaborator, "PharmaMar" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
According to Clinical.Site data, the most researched conditions in "Hôpital privé Drôme Ardèche - Clinique Pasteur" are
"Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Arthrodesis" (1 trials), "Arthroplasty, Hip, Replacement" (1 trials) and "Behavior Problem" (1 trials). Many other conditions were trialed in "Hôpital privé Drôme Ardèche - Clinique Pasteur" in a lesser frequency.
Most popular intervention types in "Hôpital privé Drôme Ardèche - Clinique Pasteur" are "Drug" (10 trials), "Other" (6 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Anastrozole" (2 trials), "Letrozole" (2 trials), "fluorouracil" (2 trials), "irinotecan hydrochloride" (2 trials) and "leucovorin calcium" (2 trials). Other intervention names were less common.
The vast majority of trials in "Hôpital privé Drôme Ardèche - Clinique Pasteur" are
11 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hôpital privé Drôme Ardèche - Clinique Pasteur
Currently, there are NaN active trials in "Hôpital privé Drôme Ardèche - Clinique Pasteur".
1 are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Hôpital privé Drôme Ardèche - Clinique Pasteur,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital privé Drôme Ardèche - Clinique Pasteur, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".